{{Rsnum
|rsid=3740393
|Gene=AS3MT
|Chromosome=10
|position=104636655
|Orientation=plus
|GMAF=0.1951
|Gene_s=AS3MT,CCDC81
|Assembly=GRCh37.p5
|GenomeBuild=37.3
|dbSNPBuild=137
|geno1=(C;C)
|geno2=(C;G)
|geno3=(G;G)
}}
{{ population diversity
| geno1=(C;C)
| geno2=(C;G)
| geno3=(G;G)
| CEU | 2.7 | 21.2 | 76.1
| HCB | 8.8 | 40.1 | 51.1
| JPT | 6.2 | 40.7 | 53.1
| YRI | 2.1 | 23.6 | 74.3
| ASW | 1.8 | 31.6 | 66.7
| CHB | 8.8 | 40.1 | 51.1
| CHD | 8.3 | 42.2 | 49.5
| GIH | 6.0 | 40.0 | 54.0
| LWK | 2.7 | 30.0 | 67.3
| MEX | 5.3 | 33.3 | 61.4
| MKK | 0.6 | 18.1 | 81.3
| TSI | 1.0 | 29.4 | 69.6
| HapMapRevision=28
}}{{PMID Auto
|PMID=19680750
|Title=Polymorphisms in arsenic metabolism genes, urinary arsenic methylation profile and cancer
}}

{{PMID Auto
|PMID=20700443
|Title=Genome-wide association studies of serum magnesium, potassium, and sodium concentrations identify six Loci influencing serum magnesium levels.
|OA=1
}}

{{PMID Auto
|PMID=23343670
|Title=Higher Magnesium Intake Is Associated with Lower Fasting Glucose and Insulin, with No Evidence of Interaction with Select Genetic Loci, in a Meta-Analysis of 15 CHARGE Consortium Studies
|OA=1
}}

{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Affy GenomeWide 6}}
{{on chip | FTDNA2}}
{{on chip | FTDNA}}